COSCIENS Biopharma Inc. COSCIENS Biopharma Inc.

COSCIENS Biopharma Inc.

CSCI

Rank in Stocks #30075
COSCIENS Biopharma Inc., a life science company, develops and commercializes... COSCIENS Biopharma Inc., a life science company, develops and commercializes products for the cosmeceutical, nutraceutical and pharmaceutical markets in the United States, Germany, the United Kingdom, and internationally. It operates through Active Ingredient and Pharmaceutical segments. The company offers active ingredients comprising oat beta glucan, a functional ingredient that supports overall health and wellness; oat powder and peptides; oat oil which is extracted from whole oat kernels by a gentle process that retains all the important biologically active components; and avenanthramides, a natural-based ingredients used to inflammation-based diseases for the cosmeceutical and pharmaceutical industries. It also provides Macrilen/Ghryvelin (macimorelin), an orally active peptidomimetic small molecule that stimulates the secretion of growth hormone from the pituitary gland. The company sells its products through its distribution network. It has license agreements with Pharmanovia, Davimed GmbH, and NK MEDITECH Ltd, as well as Agriculture Canada, Canadian Government, and University of Alberta. The company was formerly known as Aeterna Zentaris Inc. and changed its name to COSCIENS Biopharma Inc. in August 2024. COSCIENS Biopharma Inc. was incorporated in 1990 and is based in Toronto, Canada.
Share Price
$5.61
Last synced: 2026-11-17
Market Cap
$5.60M
Change (1 day)
-3.80%
Change (1 year)
-12.10%
Country

Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this

Category

Healthcare
Operating Margin for COSCIENS Biopharma Inc. (CSCI)
Operating Margin as of November 2026 TTM: -44.24%
According to COSCIENS Biopharma Inc.'s latest financial reports, its current operating margin (TTM) is -44.24%. At the end of 2025 the company had an operating margin of -139.25%.
Operating Margin history for COSCIENS Biopharma Inc. from 2000 to 2026
Operating Margin at the end of each year
Year Operating Margin Change
2026 (TTM) -44.24% -68.23%
2025 -139.25% -65.22%
2023 -400.36% 46.85%
2022 -272.64% 65.39%
2021 -164.85% 1.61%
2020 -162.24% -90.96%
2019 -1,793.98% -5,000.25%
2018 36.61% -101.46%
2017 -2,499.89% -22.74%
2016 -3,235.57% -49.45%
2015 -6,400.73% -98.12%
2014 -339,954.55% 76,301.15%
2013 -444.96% 454.74%
2012 -80.21% -10.18%
2011 -89.30% -1.94%
2010 -91.07% 140.35%
2009 -37.89% -76.63%
2008 -162.13% 96.26%
2007 -82.61% 41.84%
2006 -58.24% -1,098.97%
2005 5.83% -20.79%
2004 7.36% -185.78%
2003 -8.58% -57.78%
2002 -20.32% -49.90%
2001 -40.56% -73.09%
2000 -150.71% 0.00%
Operating Margin for similar companies or competitors
Company Operating Margin Operating Margin Difference Country
59.80% -101.35%
US
31.60% -100.71%
SE
30.13% -100.68%
FR
29.76% -100.67%
HK
31.11% -100.70%
IT
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.

Questions about COSCIENS Biopharma Inc.'s operating margin

What is COSCIENS Biopharma Inc.'s operating margin?

COSCIENS Biopharma Inc.'s operating margin is -44.24%, as of Nov 2026.

What was COSCIENS Biopharma Inc.'s operating margin in 2025?

In 2025, COSCIENS Biopharma Inc.'s operating margin was -139.25%, compared with -400.36% in 2023.

How has COSCIENS Biopharma Inc.'s operating margin changed since 2020?

From 2020 to 2025, COSCIENS Biopharma Inc.'s operating margin was highest in 2025 (-139.25%) and lowest in 2023 (-400.36%).

How does COSCIENS Biopharma Inc.'s operating margin compare with similar companies?

COSCIENS Biopharma Inc.'s operating margin (-44.24%) is lower than that of all 5 similar companies listed above. The highest among them is Royalty Pharma plc, with 59.80%.